MSAA vs BETA track™
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
MSAA
This free mobile application assists individuals with Multiple Sclerosis (MS) and their care partners in managing their condition. It provides a convenient tool to help users track and understand their MS journey, aligning with the mission to improve lives.
- MS management tool
- For MS patients
- For care partners
- Free mobile application
- Optimized for iPhone/iPad
Read full descriptionHide full description
Welcome to the new and improved My MS Manager™, a free mobile phone application created by the Multiple Sclerosis Association of America (MSAA) in partnership with @Point of Care for individuals with Multiple Sclerosis (MS) and/or their care partner. This convenient and effective tool is designed to help you manage your MS, consistent with MSAA’s mission of improving lives today. Optimized for iPhone or iPad. Need help getting the app? Have feedback? Call 1-800-772-8277, ext 178 to get assistance. If you have questions about MS that are not related to this App, please e-mail Msquestions@mymsaa.org or call 1-800-532-7667, ext. 154, for assistance.
BETA track™
This app helps patients prescribed a specific Bayer treatment for multiple sclerosis track their injections and wellness. It provides scheduled injection reminders, recommended injection sites, and a calendar view of past and future injections. Users can also log health indicators and share their data with their healthcare team.
- Scheduled injection display
- Recommended injection site guidance
- Monthly injection calendar
- Health and wellness logging
- Data sharing with healthcare team
Read full descriptionHide full description
Bayer’s BETA track™ can help support your treatment experience. BETA track™ is designed to assist you with tracking your injections. It allows you to record your injection information and wellness log. The app can only be used by patients who are at least 18 years old and have been prescribed Bayer’s treatment for relapsing-remitting multiple sclerosis. Please use these URLs to access the Important Safety Information, Full Prescribing Information, and BETACONNECT™ Instructions For Use (IFU). • Important Safety Information: www.betaseronISI.com • Prescribing Information: www.betaseronPI.com • BETACONNECT™ IFU: www.betaconnectIFU.com BETA track™ includes the following features and functions: 1. Displays scheduled injections according to the injection routine (i.e. one injection every other day). 2. Displays recommended injection sites on the body, based on the recommended injection site rotation (injection sites are based on the standard rotation scheme). 3. Displays a monthly calendar of scheduled and recorded injections. 4. Records indicators of health and wellness and summarizes the information in a chart. 5. Allows you to share your information via email, including details of your injections, with your healthcare team if you opt to do so. Bayer values your comments, questions and concerns posted on the App Store. In case of questions regarding our products, please contact your physician or pharmacist. If you are experiencing a medical emergency, contact your healthcare professional immediately. BETA track™ is not intended to offer or replace professional medical advice. If you have any questions regarding your relapsing-remitting multiple sclerosis treatment please contact your physician. BAYER, the Bayer Cross, BETAPLUS and BETASERON are registered trademarks of Bayer. BETA track and BETACONNECT are trademarks of Bayer.
Screenshots
Verdict
The clearest difference is rating: MSAA at 3.6 against BETA track™'s 1.2. MSAA also leads on review sentiment (22% vs 0%) and update cadence (every 2 months vs every 5 months). On price, ratings volume, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
MSAA holds the better App Store score, 3.6 against 1.2. Both are backed by a comparable volume of ratings — 22 and 25 respectively. Written reviews point the same way: 22% of MSAA's written reviews are positive against 0% of BETA track™'s.
MSAA ships an update every 2 months, BETA track™ every 5 months. The most recent releases landed on September 23, 2026 and September 22, 2026 respectively.
| Parameter | MSAA | BETA track™ |
|---|---|---|
| Price | Free | Free |
| Rating | 3.6 (22 ratings) — better | 1.2 (25 ratings) |
| Positive reviews | 21.9% of reviews — better | 0.0% of reviews |
| Number of ratings | 22 | 25 — better |
| Update frequency | Every 2 months — better | Every 5 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod — better | iPhone, iPad |
| Requires iOS | 14.0 — better | 17.0 |
| Further details — not scored | ||
| Size | 20 MB | 54 MB |
| Age rating | 12+ | 4+ |
| Developer | @Point of Care | Bayer Group |
Customer experience
MSAA
BETA track™
In-app purchases
MSAA
No in-app purchases
BETA track™
No in-app purchases
